Borealis Biosciences
Borealis Biosciences was established on the belief that recent scientific and translational advancements are unlocking the potential of RNA medicines to treat kidney diseases and more.
HQ location
Vancouver, Canada
Website
Enterprise value
$750m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
* | $30.0m Valuation: $750m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads